{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:51:00Z","timestamp":1792752660857,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,28]]},"DOI":"10.7759\/cureus.91168","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:31:07Z","timestamp":1756377067000},"source":"Crossref","is-referenced-by-count":1,"title":["Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fibre Layer Changes in Patients With Thyroid Eye Disease Without Optic Neuropathy: A Retrospective Observational Study"],"prefix":"10.7759","author":[{"given":"Shrinkhal","family":".","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparajita","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragati","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilakshi","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarastra P","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2011.10.005","article-title":"Epidemiology of Graves' orbitopathy (GO) and relationship with thyroid disease","volume":"26","author":"Lazarus JH","year":"2012","unstructured":"Lazarus JH. Epidemiology of Graves' orbitopathy (GO) and relationship with thyroid disease. Best Pract Res Clin Endocrinol Metab. 2012, 26:273-9. 10.1016\/j.beem.2011.10.005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref2","article-title":"The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota","volume":"92","author":"Bartley GB","year":"1994","unstructured":"Bartley GB. The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota. Trans Am Ophthalmol Soc. 1994, 92:477-588.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"ref3","unstructured":"What is thyroid eye disease (TED) or Graves\u2019 eye disease?. (2024). Accessed. March 19, 2025: https:\/\/www.aao.org\/eye-health\/diseases\/what-is-graves-disease."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1576","article-title":"Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves' orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation","volume":"154","author":"Moshkelgosha S","year":"2013","unstructured":"Moshkelgosha S, So PW, Deasy N, Diaz-Cano S, Banga JP. Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves' orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation. Endocrinology. 2013, 154:3008-15. 10.1210\/en.2013-1576","journal-title":"Endocrinology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2174\/138920211798120844","article-title":"Graves' ophthalmopathy: a review of immunogenetics","volume":"12","author":"Khalilzadeh O","year":"2011","unstructured":"Khalilzadeh O, Noshad S, Rashidi A, Amirzargar A. Graves' ophthalmopathy: a review of immunogenetics. Curr Genomics. 2011, 12:564-75. 10.2174\/138920211798120844","journal-title":"Curr Genomics"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1968.48.1.252","article-title":"Humoral factors in the pathogenesis of Graves' disease","volume":"48","author":"McKenzie JM","year":"1968","unstructured":"McKenzie JM. Humoral factors in the pathogenesis of Graves' disease. Physiol Rev. 1968, 48:252-310. 10.1152\/physrev.1968.48.1.252","journal-title":"Physiol Rev"},{"key":"ref7","article-title":"Thyroid eye disease","author":"Shah SS","year":"2023","unstructured":"Shah SS, Patel BC. Thyroid eye disease. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2009.06.030","article-title":"Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease","volume":"123","author":"Boelaert K","year":"2010","unstructured":"Boelaert K, Newby PR, Simmonds MJ, et al.. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med. 2010, 123:183.e1-9. 10.1016\/j.amjmed.2009.06.030","journal-title":"Am J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/BF03348935","article-title":"Smoking a risk factor for hypothyroidism [correction of hyperthyroidism]","volume":"16","author":"Prummel MF","year":"1993","unstructured":"Prummel MF, Wiersinga WM. Smoking a risk factor for hypothyroidism [correction of hyperthyroidism]. J Endocrinol Invest. 1993, 16:827. 10.1007\/BF03348935","journal-title":"J Endocrinol Invest"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2010.1634","article-title":"Risk factors for development or deterioration of Graves' ophthalmopathy","volume":"20","author":"Stan MN","year":"2010","unstructured":"Stan MN, Bahn RS. Risk factors for development or deterioration of Graves' ophthalmopathy. Thyroid. 2010, 20:777-83. 10.1089\/thy.2010.1634","journal-title":"Thyroid"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/17469899.2017.1276444","article-title":"Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management","volume":"12","author":"Blandford AD","year":"2017","unstructured":"Blandford AD, Zhang D, Chundury RV, Perry JD. Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management. Expert Rev Ophthalmol. 2017, 12:111-21. 10.1080\/17469899.2017.1276444","journal-title":"Expert Rev Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1993.tb00516.x","article-title":"Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic","volume":"38","author":"Perros P","year":"1993","unstructured":"Perros P, Crombie AL, Matthews JN, Kendall-Taylor P. Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic. Clin Endocrinol (Oxf). 1993, 38:367-72. 10.1111\/j.1365-2265.1993.tb00516.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1530\/acta.0.1280293","article-title":"Life events in the pathogenesis of Graves' disease: a controlled study","volume":"128","author":"Sonino N","year":"1993","unstructured":"Sonino N, Girelli ME, Boscaro M, Fallo F, Busnardo B, Fava GA. Life events in the pathogenesis of Graves' disease: a controlled study. Acta Endocrinol (Copenh). 1993, 128:293-6. 10.1530\/acta.0.1280293","journal-title":"Acta Endocrinol (Copenh)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/698470","article-title":"Relationship between clinical and immunological features of thyroid autoimmunity and ophthalmopathy during pregnancy","volume":"2015","author":"Wall JR","year":"2015","unstructured":"Wall JR, Lahooti H, Hibbert EJ, Champion B. Relationship between clinical and immunological features of thyroid autoimmunity and ophthalmopathy during pregnancy. J Thyroid Res. 2015, 2015:698470. 10.1155\/2015\/698470","journal-title":"J Thyroid Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2017.0430","article-title":"High serum cholesterol is a novel risk factor for Graves' orbitopathy: results of a cross-sectional study","volume":"28","author":"Sabini E","year":"2018","unstructured":"Sabini E, Mazzi B, Profilo MA, et al.. High serum cholesterol is a novel risk factor for Graves' orbitopathy: results of a cross-sectional study. Thyroid. 2018, 28:386-94. 10.1089\/thy.2017.0430","journal-title":"Thyroid"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2174\/1874364101610010129","article-title":"Risk factors for primary open angle glaucoma (POAG) progression: a study ruled in Torino","volume":"10","author":"Actis AG","year":"2016","unstructured":"Actis AG, Versino E, Brogliatti B, Rolle T. Risk factors for primary open angle glaucoma (POAG) progression: a study ruled in Torino. Open Ophthalmol J. 2016, 10:129-39. 10.2174\/1874364101610010129","journal-title":"Open Ophthalmol J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.06-0327","article-title":"Relationship between retinal nerve fiber layer and visual field sensitivity as measured by optical coherence tomography in chiasmal compression","volume":"47","author":"Danesh-Meyer HV","year":"2006","unstructured":"Danesh-Meyer HV, Carroll SC, Foroozan R, Savino PJ, Fan J, Jiang Y, Vander Hoorn S. Relationship between retinal nerve fiber layer and visual field sensitivity as measured by optical coherence tomography in chiasmal compression. Invest Ophthalmol Vis Sci. 2006, 47:4827-35. 10.1167\/iovs.06-0327","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.21.2.0393","article-title":"Management of Graves' ophthalmopathy: reality and perspectives","volume":"21","author":"Bartalena L","year":"2000","unstructured":"Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev. 2000, 21:168-99. 10.1210\/edrv.21.2.0393","journal-title":"Endocr Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2016.11.16","article-title":"Evaluation of retinal nerve fiber layer thickness profile in thyroid ophthalmopathy without optic nerve dysfunction","volume":"9","author":"Mugdha K","year":"2016","unstructured":"Mugdha K, Kaur A, Sinha N, Saxena S. Evaluation of retinal nerve fiber layer thickness profile in thyroid ophthalmopathy without optic nerve dysfunction. Int J Ophthalmol. 2016, 9:1634-7. 10.18240\/ijo.2016.11.16","journal-title":"Int J Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0000000000000245","article-title":"Retinal ganglion cell thickness to assess the optic nerve","volume":"35","author":"Lam BL","year":"2015","unstructured":"Lam BL. Retinal ganglion cell thickness to assess the optic nerve. J Neuroophthalmol. 2015, 35:107-8. 10.1097\/WNO.0000000000000245","journal-title":"J Neuroophthalmol"},{"key":"ref21","unstructured":"Thyroid eye disease. (2025). Accessed. March 23, 2025: https:\/\/www.thyroid.org\/thyroid-eye-disease\/."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01361-y","article-title":"Dysthyroid optic neuropathy: evaluation and management","volume":"44","author":"Dolman PJ","year":"2021","unstructured":"Dolman PJ. Dysthyroid optic neuropathy: evaluation and management. J Endocrinol Invest. 2021, 44:421-9. 10.1007\/s40618-020-01361-y","journal-title":"J Endocrinol Invest"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60091430","article-title":"Thyroid eye disease and glaucoma: a cross-sectional study comparing clinical characteristics and disease severity","volume":"60","author":"Ghenciu LA","year":"2024","unstructured":"Ghenciu LA, \u0218i\u0219u AM, Stoicescu ER, D\u0103nil\u0103 AI, Iacob R, S\u0103ndesc MA, Ha\u021began OA. Thyroid eye disease and glaucoma: a cross-sectional study comparing clinical characteristics and disease severity. Medicina (Kaunas). 2024, 60:1430. 10.3390\/medicina60091430","journal-title":"Medicina (Kaunas)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0497","article-title":"Management of Graves' ophthalmopathy","volume":"3","author":"Wiersinga WM","year":"2007","unstructured":"Wiersinga WM. Management of Graves' ophthalmopathy. Nat Clin Pract Endocrinol Metab. 2007, 3:396-404. 10.1038\/ncpendmet0497","journal-title":"Nat Clin Pract Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/395128-macular-ganglion-cell-complex-and-peripapillary-retinal-nerve-fibre-layer-changes-in-patients-with-thyroid-eye-disease-without-optic-neuropathy-a-retrospective-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:31:12Z","timestamp":1756377072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/395128-macular-ganglion-cell-complex-and-peripapillary-retinal-nerve-fibre-layer-changes-in-patients-with-thyroid-eye-disease-without-optic-neuropathy-a-retrospective-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.91168","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,28]]}}}